SEC 13F Intelligence

Opaleye Management Inc. / ADMSEUR

Opaleye Management Inc.’s Adamas Pharmaceuticals Inc Position

Does Opaleye Management Inc. own Adamas Pharmaceuticals Inc (ADMSEUR)? Not currently — the last reported position was 1.46M shares worth $7M in Q3 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$7M
Q3 2021
Shares
1.46M
% of Portfolio
+1.34%
Quarters Held
6
position exited

Position History ADMSEUR

Reported value by quarter
Q2 ’20: $2MQ2 ’20Q3 ’20: $6MQ3 ’20Q4 ’20: $6MQ4 ’20Q1 ’21: $8MQ1 ’21Q2 ’21: $9MQ2 ’21Q3 ’21: $7MQ3 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20211.46M$7M+1.34%
Q2 20211.67M$9M+1.47%
Q1 20211.67M$8M+1.18%
Q4 20201.49M$6M+0.84%
Q3 20201.49M$6M+1.20%
Q2 2020960.0K$2M+0.50%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Opaleye Management Inc.’s full portfolio or all institutional holders of ADMSEUR.